Shares of Semler Scientific, Inc. (NASDAQ:SMLR – Get Free Report) gapped down before the market opened on Friday . The stock had previously closed at $61.15, but opened at $53.99. Semler Scientific shares last traded at $54.80, with a volume of 637,150 shares traded.
Wall Street Analysts Forecast Growth
Separately, Lake Street Capital lifted their target price on Semler Scientific from $40.00 to $71.00 and gave the company a “buy” rating in a research report on Friday.
Read Our Latest Stock Report on SMLR
Semler Scientific Price Performance
Semler Scientific (NASDAQ:SMLR – Get Free Report) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.72 EPS for the quarter, topping the consensus estimate of $0.37 by $0.35. The firm had revenue of $13.51 million for the quarter. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%.
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the stock. Rhumbline Advisers grew its position in shares of Semler Scientific by 27.1% in the 2nd quarter. Rhumbline Advisers now owns 6,197 shares of the company’s stock valued at $213,000 after acquiring an additional 1,320 shares during the period. Dimensional Fund Advisors LP lifted its stake in Semler Scientific by 18.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 126,177 shares of the company’s stock valued at $4,341,000 after purchasing an additional 19,552 shares during the last quarter. AQR Capital Management LLC grew its holdings in Semler Scientific by 150.1% during the second quarter. AQR Capital Management LLC now owns 140,498 shares of the company’s stock worth $4,833,000 after purchasing an additional 84,314 shares during the period. Newbridge Financial Services Group Inc. bought a new stake in Semler Scientific in the second quarter valued at approximately $34,000. Finally, Shariaportfolio Inc. acquired a new stake in shares of Semler Scientific in the third quarter valued at approximately $3,618,000. 49.37% of the stock is currently owned by institutional investors.
About Semler Scientific
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.
Featured Stories
- Five stocks we like better than Semler Scientific
- Conference Calls and Individual Investors
- Bloom Energy: Powering the Future With Decentralized Energy
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- What Do S&P 500 Stocks Tell Investors About the Market?
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.